ROCHESTER, N.Y. (May 14, 2025)—Neuroscience technology innovator Cognivue^®, today announced a scientific breakthrough with the launch of the Cognivue Amyloid Risk Measure (CARM)*, a novel metric that predicts the likelihood of the presence of amyloid—a key biomarker of Alzheimer’s disease (AD).¹ Now available as an optional feature on the Cognivue Clarity^® device (based on FDA-cleared technology), CARM represents a significant advancement in the early detection of Alzheimer’s by helping healthcare providers identify those at risk of cognitive impairment, even before symptoms emerge.

Over time, stress and anxiety can build to a point where life’s challenges become overwhelming and cause physical effects. Now, in ACS Applied Materials & Interfaces, researchers report a dental floss pick with a built-in sensor that could monitor stress as part of a daily routine. The device, which accurately senses levels of the stress hormone cortisol in minutes, could help users recognize when it’s time to get help.

In many neurodegenerative diseases, proteins misfold and clump together in brain tissue. Scientists developed a new therapy made of peptides and a sugar that naturally occurs in plants. The therapeutic molecules self-assemble into nanofibers, which bond to the neuron-killing proteins. Now trapped, the toxic proteins can no longer enter neurons and instead harmlessly degrade.

Researchers at the University of the Basque Country (EHU) have explored how a combination of photovoltaic energy and heat pumps could be used to carry out the energy retrofitting of social rental housing. The Basque Government’s Zero Plan was used as the basis, and the technologies that the European Union is keen to promote were assessed. The buildings in Araba-Álava were generally found to offer the greatest potential for implementing the system.